Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
All content for Brain Trash: Psychiatry from DSM to Dumpster Fire is the property of Maria Ingalla & Tabitha Arey and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
Send us questions here! Summary In this episode, Maria and Tabitha explore the intricate connections between neurodivergence and connective tissue disorders, particularly focusing on Ehlers-Danlos Syndrome and POTS. They discuss the prevalence of these conditions in women, the role of collagen in bodily functions, and the challenges faced by patients in the healthcare system, including gaslighting and misunderstandings in treatment. The conversation emphasizes the need for better education, a...
Brain Trash: Psychiatry from DSM to Dumpster Fire
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
